SREBF1 and metabolic syndrome: Secondary aims include the analysis of the association between the cognitive impairment and psychopathological status and, in a subgroup of patients, the evaluation of the effect of SREBF1 rs11868035 genetic polymorphism on both cognitive functioning and MetS.